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Abstract
Objective:  To  assess  the  frequency  of  overweight  and  obesity  in  children  and  adolescents  with
autism spectrum  disorder  (ASD)  and  with  attention  deﬁcit/hyperactivity  disorder  (ADHD)  and
their parents,  in  comparison  with  children  and  adolescents  without  developmental  disorders.
Methods: Anthropometric  measures  were  obtained  in  69  outpatients  with  ASD  (8.4±4.2  years
old), 23  with  ADHD  (8.5±2.4)  and  19  controls  without  developmental  disorders  (8.6±2.9)
between  August  and  November  2014.  Parents  of  patients  with  ASD  and  ADHD  also  had  their
anthropometric  parameters  taken.  Overweight  was  deﬁned  as  a  percentile  ≥85;  obesity  as  a
percentile  ≥95;  and  underweight  as  a  percentile  ≤5.  For  adults,  overweight  was  deﬁned  as  a
BMI between  25  and  30kg/m2 and  obesity  as  a  BMI  higher  than  30kg/m2.
Results:  Children  and  adolescents  with  ASD  and  ADHD  had  higher  BMI  percentile  (p<0.01)  and
z-score (p<0.01)  than  controls,  and  increased  frequency  of  overweight  and  obesity  (p=0.04).
Patients  with  ASD  and  ADHD  did  not  differ  between  them  in  these  variables,  nor  regarding
abdominal circumference.  Parents  of  children  with  ASD  and  ADHD  did  not  differ  between
themselves.
Conclusions:  Children  and  adolescents  with  ASD  and  ADHD  are  at  a  higher  risk  of  overweight
and obesity  than  children  without  developmental  problems  in  the  community.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY  license  (https://creativecommons.org/licenses/by/4.0/).
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Frequência  de  sobrepeso  e  obesidade  em  crianc¸as e  adolescentes  com  autismo  e
transtorno  do  déﬁcit  de  atenc¸ão/hiperatividade
Resumo
Objetivo:  Avaliar  a  frequência  de  sobrepeso  e  obesidade  em  crianc¸as  e  adolescentes  com
transtorno  do  espectro  do  autismo  (TEA)  e  transtorno  do  déﬁcit  de  atenc¸ão/hiperatividade
(TDAH) e  em  seus  pais,  em  comparac¸ão  com  crianc¸as  e  adolescentes  da  comunidade  sem
transtornos  do  desenvolvimento.
Métodos:  Medidas  antropométricas  foram  coletadas  de  69  pacientes  com  TEA  (8,4±4,2  anos),
23 com  TDAH  (8,5±2,4)  e  19  controles  sem  transtornos  desenvolvimentais  (8,6±2,9)  entre
agosto e  novembro  de  2014.  Os  pais  dos  pacientes  com  TEA  e  TDAH  também  foram  avalia-
dos em  relac¸ão  aos  parâmetros  antropométricos.  Sobrepeso  foi  deﬁnido  como  percentil  ≥85;
obesidade  como  percentil  ≥95;  e  baixo  peso  como  percentil  ≤5.  Para  os  adultos,  sobrepeso  foi
deﬁnido como  IMC  entre  25  e  30kg/m2 e  obesidade,  IMC  acima  de  30kg/m2.
Resultados:  Crianc¸as  e  adolescentes  com  TEA  e  TDAH  exibiram  maior  percentil  (p<0,01)  e
escore-z (p<0,01)  do  IMC  em  relac¸ão  aos  controles,  bem  como  frequência  mais  elevada  de
sobrepeso  e  obesidade  (p=0,04).  Os  pacientes  com  TEA  e  TDHA  não  diferiram  entre  si  quanto
a essas  variáveis  ou  quanto  à  circunferência  abdominal.  Os  pais  das  crianc¸as  com  TEA  e  TDAH
também não  diferiram  entre  si.
Conclusões:  Crianc¸as  e  adolescentes  com  TEA  e  TDAH  estão  em  maior  risco  de  ter  sobrepeso  e
obesidade em  relac¸ão  a  crianc¸as  da  comunidade  sem  problemas  do  desenvolvimento.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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taking  methylphenidate,  but  medical  records  information
indicated  that  its  use  was  for  ‘‘disruptive  behavior’’’  (e.g.,ntroduction
revalence  of  overweight  and  obesity  in  developed  countries
s  alarming  and  reaches  31.8%  of  children  and  adolescents.1
n  the  US,  despite  continued  efforts  to  reduce  these  public
ealth  problems,  rates  have  been  stable  in  the  last  decade.1
n  Brazil,  epidemiological  studies  have  shown  an  increased
requency  of  overweight  and  obesity  in  this  age  group.2,3
omparison  of  the  1989  National  Survey  on  Health  and
utrition  (PNSN)  and  the  2008--2009  Consumer  Expenditure
urvey  shows  that  overweight  frequency  in  children  between
ve  and  nine  years  old  increased  from  about  9--33%.3
International  studies  have  found  an  association  between
verweight/obesity  and  psychiatric  disorders  in  children,
uch  as  autism  spectrum  disorder  (ASD)  and  atten-
ion  deﬁcit/hyperactivity  disorder  (ADHD).  Nevertheless,
hether  this  association  is  characteristic  of  ASD  and  ADHD  or
ommon  to  behavioral  and  developmental  problems  in  gen-
ral  remains  unclear.  Furthermore,  the  association  is  likely
o  be  bidirectional;  that  is,  not  only  behavioral  problems
ay  lead  to  obesity,  but  obesity  may  be  a  risk  factor  for  the
evelopment  of  behavioral  and  developmental  problems.4
Most  studies  of  the  nutritional  status  of  young  people  and
dults  with  ADHD  reports  a  high  frequency  of  overweight  and
besity,  as  well  as  a  mean  body  mass  index  (BMI)  higher  in
atients  with  ADHD  compared  to  controls  without  develop-
ental  disorders.5--7 The  frequency  of  obesity  is  higher  in
dults  with  ADHD  than  in  adults  with  childhood  ADHD  his-
ory,  but  whose  symptoms  remitted  in  adulthood.8 Similarly,
bese  young  people  also  have  higher  frequency  of  ADHD.5urthermore,  behavioral  problems  such  as  ADHD  hinder  obe-
ity  treatment.9
h
sSimilarly,  studies  also  reported  that  children  and  adoles-
ents  with  ASD  are  more  often  overweight  and  obese.10--13
n  ASD,  weight  changes  have  been  associated  with  sleep
isorders,10,11 older  age,11 and  using  food  as  a  reward,12
mong  others.  In  addition,  parents  of  children  with  autism
re  also  more  frequently  obese.14 These  factors  suggest
 complex  interaction  between  genetic,  molecular,  and
ehavioral  factors.
Despite  these  alarming  data,  there  are  no  studies  of  the
utritional  status  of  children  with  ASD  and  ADHD  in  Brazil.
n  addition,  few  studies  have  compared  the  BMI  and/or  the
verweight  frequency  in  different  developmental  disorders.
In  this  context,  the  aim  of  this  study  was  to  evaluate
he  frequency  of  overweight  and  obesity  in  children  and
dolescents  with  ASD  and  ADHD  and  their  parents.
ethod
hildren  and  adolescents  seen  in  the  outpatient  clinics  of
SD  (n=69)  and  Attention  Deﬁcit  (n=23)  of  the  Psychiatry  Ser-
ice  of  the  Hospital  das  Clinicas,  Federal  University  of  Minas
erais  (UFMG),  Brazil,  and  their  parents  were  invited  to  par-
icipate  in  this  study.  Data  were  collected  between  August
nd  November  2014,  and  none  of  those  invited  declined  to
articipate.  All  patients  with  ASD  and  ADHD  met  the  diag-
ostic  criteria  of  the  DSM-5.15 It  was  considered  the  gold
tandard.  Patients  in  ASD  group  had  no  ADHD  as  comorbidity
nd  vice  versa.  Noteworthy,  some  patients  with  ASD  wereetero  or  self-aggressiveness).  The  control  group  (n=19)  con-
isted  of  children  and  adolescents  with  normal  psychomotor
tism  
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fer  with  respect  to  anthropometric  measurements  (Table  4).Overweight  and  obesity  in  children  and  adolescents  with  au
development,  recruited  from  the  local  community.  The
study  was  approved  by  the  Research  Ethics  Committee  of
UFMG  and  all  participants  and/or  legal  guardians  gave  their
written  informed  consent  before  entering  the  study.
Patients  and  controls  were  interviewed  using  a  structured
questionnaire  to  collect  demographic  (age  and  sex  of  child
and  guardians)  and  clinical  data.  Parents  of  children  with
ASD  responded  to  the  inventory  Social  and  Communication
Disorders  Checklist  (SCDC)16 and  parents  of  children  with
ADHD  respond  to  the  Swanson,  Nolan,  and  Pelham  scale
-- version  IV  (SNAP-IV).17 SCDC  is  a  self-completion  ques-
tionnaire  with  12  questions  that  assesses  the  severity  of
behaviors  related  to  autism  in  the  last  six  months.16 SNAP-
IV  is  a  self-administered  instrument  that,  in  its  version  of
26  items,  evaluates  the  severity  of  inattentive,  hyperac-
tive/impulsive,  and  opponent/deﬁant  behavior.17
All  subjects  included  in  the  study  had  their  weight
(kg)  and  height  (m)  measured  at  the  time  of  interview.
BMI  was  calculated  using  the  formula:  weight  (expressed
in  kg)  divided  by  height  (expressed  in  meters)  squared
(kg/m2).  Age  and  sex-speciﬁc  BMI  z-score  and  percentiles  of
patients  and  controls  were  calculated  using  CDC  2000  growth
charts.18 Overweight  was  deﬁned  as  a  percentile  ≥85;  obe-
sity  as  a  percentile  ≥95;  and  underweight  as  a  percentile
≤5.  For  adults,  overweight  was  deﬁned  as  BMI  between  25
and  30kg/m2 and  obesity  as  BMI  over  30kg/m2.
Subjects  were  also  evaluated  for  abdominal  circumfer-
ence,  which  was  also  converted  into  percentiles  according  to
CDC  2007--2010  graphics.19 Anthropometric  measurements
were  taken  with  participants  in  light  clothes  and  barefoot,
using  a  portable  digital  scale,  wall  mounted  stadiometer,
and  inelastic  tape  measure.  Waist  circumference  was  mea-
sured  over  the  skin  in  the  upper  part  of  the  lateral  border
of  the  right  ilium  and  at  the  end  of  normal  expiration,  and
the  nearest  millimeter  was  recorded.20
Statistical  analyzes  were  performed  using  SPSS  soft-
ware  version  22.0  (SPSS  Inc.,  Chicago,  IL,  USA).  Descriptive
statistics  were  used  to  present  the  sociodemographic  and
clinical  characteristics  of  the  sample.  Association  between
dichotomous  variables  was  assessed  with  Pearson’s  chi-
square  or  Fisher’s  exact  test,  as  appropriate.  Continuous
variables  were  expressed  as  mean  and  standard  devia-
tion.  All  variables  were  tested  for  normal  distribution  using
the  Shapiro--Wilk  test  and  no  data  had  a  normal  distri-
bution.  Therefore,  the  differences  between  groups  were
compared  using  the  Mann--Whitney  test  or  Kruskal--Wallis
T
o
o
Table  1  Comparison  of  body  mass  index  (BMI)  and  weight  chan
disorder (ADHD)  and  autism  spectrum  disorder  (ASD)  and  controls.
Controls  (n=19)  AD
BMI  percentilea 35.8±28.5  64.
BMI Z-scorea −0.55±1.13  0.
Weight changes  
Underweight  21.0%  0.
Normal 73.7%  65.
Overweight  0.00%  17.
Obesity 5.3%  17.
BMI, body mass index. Bold indicates p-value signiﬁcant at <0.05.
a Values are expressed as mean±standard deviation.and  ADHD  73
est,  as  appropriate.  Correlations  were  investigated  using
he  Spearman  coefﬁcient.  All  p-values  were  two-tailed  and
he  signiﬁcance  level  of  p<0.05  was  used.
esults
here  was  prevalence  of  male  in  the  ASD  (86.9%),  ADHD
78.9%),  and  control  (86.9%)  groups.  There  was  no  statis-
ically  signiﬁcant  difference  between  groups  (p=0.66).  Also,
here  was  no  difference  in  age  between  individuals  with  ASD
8.4±4.2;  range:  2--18  years),  ADHD  (8.5±2.4;  range:  5--15
ears),  and  controls  (8.6±2.9;  range:  5--15  years)  (p=0.603).
Age  and  sex-speciﬁc  BMI  z-score  and  percentiles  of  con-
rols  were  signiﬁcantly  lower  than  those  of  patients  with  ASD
nd  ADHD  (Table  1).  Similar  ﬁndings  were  seen  when  groups
ere  compared  regarding  weight  change  proportions,  with
igher  percentage  of  overweight  and  obesity  in  both  groups
f  patients  (ASD  and  ADHD)  compared  with  the  control  group
Table  1).  On  the  other  hand,  there  was  no  signiﬁcant  dif-
erence  between  patients  with  ADHD  and  ASD  in  any  of  the
omparisons  (Table  1).  Regarding  waist  circumference  per-
entile,  groups  with  ASD  (56.4±29.9)  and  ADHD  (65.0±18.3)
lso  did  not  differ  (p=0.453).
The  severity  of  ADS  symptoms  did  not  correlate  with
nthropometric  measurements  (Table  2).  In  ADHD  group,
he  BMI  percentile  correlated  negatively  with  the  sever-
ty  of  opposition  and  deﬁance  symptoms  of  and  there  was
o  correlation  with  inattention  or  hyperactivity/impulsivity
ymptoms.
Of  ADHD  patients,  20  (87%)  were  taking  psychiatric  drugs
Table  3).  Among  ASD  patients,  26  (37.7%)  were  taking  psy-
hiatric  drugs.  In  ASD  group,  there  was  a tendency  for  a
igher  percentage  of  BMI  (p=0.06)  in  participants  taking
isperidone.  Of  the  21  participants  taking  risperidone,  5
23.8%)  of  guardians  spontaneously  reported  seen  a  signiﬁ-
ant  increase  in  appetite  after  drug  initiation.  Of  the  total
8  participants  in  use  of  methylphenidate,  when  faced  with
n  open  question  on  side  effects,  13  (44.8%)  guardians  spon-
aneously  reported  that  there  was  a  signiﬁcant  decrease  in
ppetite  with  the  drug.
Parents  of  participants  with  ASD  and  ADHD  did  not  dif-here  was  also  no  signiﬁcant  difference  between  parents
f  individuals  with  ASD  and  ADHD  regarding  frequency  of
verweight  and  obesity  (p=0.34).
ge  between  individuals  with  attention  deﬁcit/hyperactivity
HD  (n=23)  ASD  (n=69)  p-value
6±30.2  62.9±32.0  0.006
87±1.42  0.49±1.51  0.002
0.044
00%  6.7%
2%  53.3%
5%  18.3%
4%  21.7%
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Table  2  Correlation  of  clinical  features  with  body  mass  index  (BMI)  and  waist  circumference  in  individuals  with  autism  spectrum
disorder (ASD)  and  attention  deﬁcit/hyperactivity  disorder  (ADHD).
BMI  percentile  BMI  Z-score  AC  percentile
ASD  (n=69)
SCDC
Correlation  coefﬁcient  0.059  0.062  −0.009
Sig. (2  tailed)  0.727  0.717  0.960
ADHD (n=23)
SNAP-I
Correlation  coefﬁcient −0.200 −0.251 −0.667
Sig.  (2  tailed) 0.555 0.457 0.219
SNAP-HI
Correlation  coefﬁcient  −0.230  −0.331  0.803
Sig. (2  tailed)  0.496  0.320  0.102
SNAP-OD
Correlation  coefﬁcient −0.621 −0.370  0.410
Sig. (2  tailed) 0.041 0.263 0.493
AC, abdominal circumference; SCDC, Social and Communication Disorders Checklist; SNAP-I, SNAP-IV inattention subscale; SNAP-HI,
SNAP-IV hyperactivity subscale; SNAP-OD, SNAP-IV opposition and deﬁance subscale. Bold indicates p-value signiﬁcant at <0.05.
Table  3  Analysis  of  associations  between  drug  use  and  body  mass  index  (BMI)  and  waist  circumference  in  individuals  with
autism spectrum  disorder  (ASD)  and  attention  deﬁcit/hyperactivity  disorder  (ADHD).
BMI  percentile
(mean±SD)
BMI  Z-score
(mean±SD)
AC  percentile
(mean±SD)
ASD  (n=69)
Risperidone
Yes  (n=19)  72.6±26.8  1.0±1.3  63.7±27.7
No (n=50)  58.4±33.6  0.2±1.5  47.5±31.0
p-value 0.068  0.076  0.132
Methylphenidate
Yes (n=9)  56.3±31.8  0.4±1.5  49.4±28.5
No (n=60)  64.0±32.3  0.5±1.5  59.2±30.6
p-value 0.627  0.641  0.333
Antidepressant
Yes (n=65)  49.3±39.6  0.3±1.6  50.6±33.7
No (n=4)  63.8±31.7  0.5±1.5  57.2±29.9
p-value 0.501  0.483  0.712
ADHD (n=23)
Risperidone
Yes  (n=2)  59.6±18.7  0.2±0.5  64.3±18.8
No (n=21)  65.1±31.3  0.92±1.8  75.0±0.0
p-value 0.640  0.569  0.625
Methylphenidate
Yes (n=19)  63.6±30.2  0.8±1.5  95.0±0.0
No (n=4)  74.4±32.7  1.1±1.4  63.0±17.1
p-value 0.409  0.557  0.125
Antidepressant
Yes (n=2)  70.3±33.8  0.7±1.2  75.0±0.0
No (n=21)  64.1±30.7  0.9±1.5  63.6±19.3
p-value 0.791  0.957  0.417BMI, body mass index; AC, abdominal circumference.
Overweight  and  obesity  in  children  and  adolescents  with  autism  and  ADHD  75
Table  4  Anthropometric  data  and  frequency  of  weight  change  of  parents  of  individuals  with  attention  deﬁcit/hyperactivity
disorder (ADHD)  and  autism  spectrum  disorder  (ASD).
Parents  of  individuals
with  ASD  (n=69)
Parents  of  individuals
with  ADHD  (n=23)
p-value
Weight  (kg)a 70.6±22.8  65.1±12.2  0.703
Height (m)a 1.6±0.1  1.6±0.1  0.241
BMI (kg/m2)a 26.8±6.9  25.8±4.0  0.979
Abdominal circumference  (cm)a 84.5±13.1 86.3±10.6  0.273
Weight change
Normal  BMI 37  (53.6%) 13  (56.5%) 0.336
Overweight  17  (24.6%) 8  (34.8%)
Obesity 15  (21.7%)  2  (8.7%)
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a Values are expressed as mean±standard deviation.
Discussion
Overweight  and  obesity  are  public  health  problems  in  the
general  population.  The  incidence  of  many  chronic  diseases
in  adulthood  is  directly  related  to  childhood  obesity.1 Obe-
sity  increases  the  risk  of  children  having  short  and  long
term  health  problems,  such  as  diabetes,  cardiovascular  and
psychosocial  diseases.  International  studies  indicate  that
children  and  adolescents  with  ASD  and  ADHD  may  be  particu-
larly  vulnerable  to  such  weight  changes.4--13 This  work  shows
that  Brazilian  children  and  adolescents  with  ASD  and  ADHD
also  appear  to  be  more  prone  to  overweight  and  obesity
compared  to  the  general  population.
Few  Brazilian  studies  have  investigated  this  issue.
Domingues  evaluated  30  children  in  a  special  school  of
Campo  Grande  and  found  that  four  (13.3%)  were  obese  and
seven  (23.3%)  were  underweight.21 Emidio  et  al.  evaluated
23  autistic  children  and  adolescents  and  found  that  three
(13%)  were  underweight,  ﬁve  (21.7%)  were  overweight,  and
six  (26.1%)  were  obse.22 Although  both  studies  indicate  high
rates  of  overweight  and  obesity  in  children  and  adolescents
with  ASD,  the  absence  of  a  control  group  signiﬁcantly  limited
the  interpretation  of  the  ﬁndings.
Nascimento  et  al.  found  no  difference  in  frequency  of
overweight  among  children  and  adolescents  with  ‘‘ADHD-
indicative’’  and  controls,  or  when  comparing  the  BMI  of
both  the  groups.23 A  limitation  of  this  study  is  the  inclusion
of  children  with  only  ‘‘ADHD-indicative’’,  without  a  con-
ﬁrmed  diagnosis  of  the  disorder.  Moreover,  the  study  did  not
properly  set  the  variable  ‘‘overweight’’,  as  well  as  directly
compared  the  BMI  of  the  two  groups,  instead  of  compar-
ing  the  adjusted  percentile  for  age.  In  contrast,  Paranhos
et  al.  reported  that  all  70  children  and  adolescents  with
ADHD  evaluated  at  the  University  Hospital  of  Brasilia  were
eutrophic.24 However,  this  study  also  did  not  adequately
deﬁned  the  weight  change  and  did  not  use  the  percentile
variable  and/or  the  age  and  sex-speciﬁc  BMI  z-scores.
There  are  few  published  studies  that  compared  BMI  and
frequency  of  overweight/obesity  between  developmental
disorders.  Curtin  et  al.  performed  a  review  of  medical
records  of  children  and  adolescents  in  care  in  a  tertiary
center  for  neuropsychiatric  disorders  and  found  a  frequency
of  overweight  and  obesity  of,  respectively,  29%  and  17.3%
in  ADHD  patients  and  35.7%  and  19%  in  ASD  patients.25
i
g
i
the  Curtin  study  limitation  is  that  anthropometric  mea-
urements  were  obtained  from  medical  records,  there  was
o  standardization  in  the  form  of  data  collection.  More-
ver,  there  was  no  control  group  or  comparisons  between
roups.  Chen  et  al.  evaluated  only  the  frequency  of  obe-
ity  (BMI  ≥95th  percentile)  in  children  and  adolescents
ith  chronic  desases  (physical,  developmental,  and  behav-
oral)  and  found  frequency  of  23.4%  in  ASD  patients  and
8.9%  in  ADHD  patients.26 The  study  by  Chen  et  al.  also
as  a  number  of  limitations,  such  as  using  data  from  the
ational  Survey  of  Children’s  Health  (NSCH  2003),  in  which
ll  information  was  collected  by  telephone;  the  possibility
f  having  the  same  participant  with  comorbidities  including
SD  and  ADHD  at  the  same  time;  and  no  statistical  calcula-
ion  for  comparison  between  groups.  More  recently,  Philips
t  al.  used  data  from  the  National  Health  Interview  Sur-
ey  (2008--2010)  to  compare  the  frequency  of  underweight,
verweight,  and  obesity  in  adolescents  with  various  devel-
pmental  disorders.13 Obesity  and  underweight  were  more
ommon  in  all  neurodevelopmental  disorders,  but  the  fre-
uency  of  obesity  was  particularly  high  in  the  subgroup
ith  ASD  (31.8%),  whereas  patients  with  ADHD  had  a  lower
revalence  (17.6%).  The  frequency  of  overweight  was  simi-
ar  between  the  groups  with  developmental  disorders  (ASD:
0.9%;  ADHD:  18.0%)  and  children  with  typical  development
18.2%).  The  study  should  also  be  interpreted  with  caution
ecause  of  its  limitations,  including  the  medical  and  anthro-
ometric  data  collection  only  by  interviewing  the  guardians;
on-pairing  by  sex  between  the  control  and  ASD  and  ADHD
roups,  there  was  prevalence  of  female  adolescents  in  the
ontrol  group13; and  the  high  frequency  of  comorbidities
etween  ASD  and  ADHD  (60%  of  ASD  patients  also  had
DHD).
A  common  limitation  of  many  studies  of  weight  changes
n  people  with  ASD  and  ADHD  is  that  the  authors  use  only
he  BMI  as  base.  Such  an  approach  does  not  allow  the  direct
easurement  of  body  composition  and/or  distribution  of
ody  fat,  there  may  be  increased  BMI  because  of  increased
uscle  mass.  Waist  circumference  measurement  is  easy  to
btain  and  can  indicate  the  presence  of  visceral  adiposity
n  children.27 In  this  context,  the  present  study  showed  that
roups  with  ASD  and  ADHD  did  not  differ  from  each  other  or
n  relation  to  BMI  (high  compared  to  control)  nor  in  relation
o  waist  circumference.
7l
s
p
d
a
o
d
s
t
b
t
t
h
a
r
t
w
A
A
a
m
o
c
p
w
A
u
c
c
e
i
m
l
i
f
o
i
A
F
n
w
c
A
n
p
w
t
i
p
t
m
c
n
s
c
t
c
a
t
h
r
g
a
e
t
o
a
g
F
C
T
d
(
A
B
C
T
A
D
(
R6  
The  severity  of  ASD  and  ADHD  symptoms  did  not  corre-
ate  with  weight  change.  However,  opposition  and  deﬁance
ymptoms  negatively  correlated  with  BMI  percentile  in  ADHD
articipants.  Korczak  et  al.  noted  that  ADHD  could  pre-
ict  obesity  later  in  life,  but  according  to  the  authors  this
ssociation  would  be  completely  explained  by  the  presence
f  behavior  disorder  in  childhood.28 Although  opposition-
eﬁance  and  behavior  symptoms  are  often  correlated,  this
eemingly  discrepant  ﬁnding  raises  the  question  of  whether
hese  conditions  may  have  differential  effect  on  feeding
ehavior  (e.g.,  refusal  to  eat  and  frequent  tantrums  related
o  food  in  the  opponent-deﬁant  disorder).
Consistent  with  the  medical  literature,  there  was  a
rend  towards  the  association  of  risperidone  intake  and
igher  BMI  percentile  in  ASD  patients.  Increased  appetite
nd  metabolic  alterations  are  common  side  effects  of
isperidone.20 Interestingly,  although  the  parents  of  children
aking  methylphenidate  have  reported  decreased  appetite
ith  this  substance,  this  was  not  reﬂected  in  lower  BMI  in
DHD  children.  It  was  not  possible  to  compare  the  BMI  of
DHD  children  taking  or  not  taking  methylphenidate  because
lmost  all  of  them  were  taking  this  drug.  However,  although
ethylphenidate  common  side  effect  is  decreased  appetite,
ther  studies  have  found  no  difference  in  BMI  between  ADHD
hildren  receiving  or  not  methylphenidate.6,7
Finally,  it  was  seen  for  the  ﬁrst  time  in  the  literature  that
arents  of  children  with  ASD  and  ADHD  did  not  differ  in  BMI,
aist  circumference,  and  frequency  of  overweight/obesity.
lthough  nearly  half  of  parents  are  overweight/obese,
nfortunately  it  was  not  possible  to  compare  them  with  the
ontrol  group  because  the  children  and  adolescents  of  the
ontrol  group  were  examined  at  school  without  the  pres-
nce  of  their  parents.  Some  studies  suggest  that  obesity
n  parents  is  a  risk  factor  for  ASD  and  ADHD.  However,
ore  investigations  are  needed  to  assess  factors  under-
ying  this  possible  association,  such  as  genetic/epigenetic
nﬂuence,  family  habits,  inﬂammatory  changes  resulting
rom  obesity  during  gametogenesis  and  pregnancy,  among
thers.14,29
These  results  should  be  interpreted  with  caution.  Due  to
ts  cross-cutting  nature,  one  cannot  infer  causality  between
SD,  ADHD,  and  higher  frequency  of  overweight  and  obesity.
urthermore,  this  study  included  a  relatively  small  conve-
ience  sample  of  ADHD  patients  and  controls.  All  patients
ere  recruited  from  a  single  tertiary  center  where  more
omplex  cases  with  more  pronounced  symptoms  of  ADHD  and
SD  are  usually  treated,  which  could  compromise  the  exter-
al  validity  of  the  study.  Moreover,  there  were  a  signiﬁcant
roportion  of  underweight  children  in  the  control  group,
hich  highlighted  a  peculiarity  of  the  sample  involved  in
his  work.  The  lack  of  waist  circumference  measurement
n  the  controls  and  anthropometric  measurement  in  their
arents  is  also  a  limitation  that  should  be  mentioned.  On
he  other  hand,  consecutive  sampling,  direct  and  careful
easurement  of  anthropometric  parameters  of  patients  and
ommunity  controls  without  developmental  disorders,  diag-
osis  and  evaluation  of  patients  by  experienced  clinicians,
ample  matched  by  gender  and  age,  and  the  exclusion  of
omorbid  cases  of  ADHD  and  ASD  are  strengths  of  the  study
hat  should  be  highlighted.
In  summary,  this  study  showed  that  children  and  adoles-
ents  with  ASD  and  ADHD  followed-up  in  outpatient  clinicsKummer  A  et  al.
re  at  increased  risk  of  overweight  and  obesity  than  their
ypically  developing  peers.  Drugs  such  as  risperidone  may
ave  some  causal  role  and  patients  taking  these  substances
equire  close  monitoring  for  metabolic  changes.  However,
enetic  and  environmental  factors  (e.g.,  poor  eating  habits
nd  sedentary  lifestyle)  should  also  be  considered.  We
mphasize  that  obesity  and  overweight  are  general  risk  fac-
ors  for  disorders  and  responsible  for  worsening  the  quality
f  life.  Thus,  it  is  very  important  that  physicians  routinely
ssess  the  weight  of  their  patients  with  ASD  and  ADHD  and
ive  them  advises  on  healthy  living  habits.
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